13D/13G Filings - CYCLACEL PHARMACEUTICALS INC 6 (CYCCP)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2021-03-18
12:59 pm
Purchase		2021-03-1213GCyclacel Pharmaceuticals, Inc.
CYCC		SPHERA FUNDS MANAGEMENT LTD.2,112
6.290%		2,112increase
(New Position)		Filing
History
2021-02-16
09:57 am
Purchase		2020-12-3113GCyclacel Pharmaceuticals, Inc.
CYCC		CVI Investments, Inc.1,171
4.900%		5increase
(+0.46%)		Filing
History
2021-02-12
4:58 pm
Purchase		2020-12-1813GCyclacel Pharmaceuticals, Inc.
CYCC		ACORN BIOVENTURES, L.P.9,769
9.990%		9,769increase
(New Position)		Filing
History
2021-02-11
09:41 am
Unchanged		2020-12-3113GCyclacel Pharmaceuticals, Inc.
CYCC		Renaissance Technologies LLC0
0.000%		0
(Unchanged)		Filing
History
2021-02-09
2:28 pm
Purchase		2020-12-3113GCyclacel Pharmaceuticals, Inc.
CYCC		Hudson Bay Capital Management LP1,719
7.160%		1,719increase
(New Position)		Filing
History
2021-01-08
9:59 pm
Purchase		2020-12-2313GCyclacel Pharmaceuticals, Inc.
CYCC		Ikarian Capital, LLC1,667
8.200%		1,667increase
(New Position)		Filing
History
2020-12-28
3:02 pm
Purchase		2020-12-2213GCyclacel Pharmaceuticals, Inc.
CYCC		PURA VIDA INVESTMENTS LLC1,979
8.880%		1,979increase
(New Position)		Filing
History
2020-12-23
4:42 pm
Purchase		2020-12-2313GCyclacel Pharmaceuticals, Inc.
CYCC		Aspire Capital Fund LLC1,125
5.050%		1,125increase
(New Position)		Filing
History
Goto Prev, 0, 1